Allspring Global Investments’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-170,379
Closed -$262K 2821
2022
Q1
$262K Sell
170,379
-352,534
-67% -$542K ﹤0.01% 2481
2021
Q4
$1.28M Buy
+522,913
New +$1.28M ﹤0.01% 1790